Elevated thyroglobulin (Tg) levels during the phase of thyrotoxicosis and decreasing during the subsequent hypothyroidism have been observed in nivolumab-induced destructive thyroiditis [88]. The gene discussed is TG; the disease is thyrotoxicosis.